Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 4 Terminated 2 Recruiting 2 Withdrawn 1 Unknown 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 6 Gastrointestinal 4 Genitourinary 3 Breast 3 Sarcoma 2 Other solid neoplasm 1 Lymphoid 1 CNS 1

Conditions

Interventions

Temozolomide 19 Magnetic Resonance Spectroscopy 16 Radiosurgery 12 Bevacizumab 12 Radiotherapy 10 Radiation 8 pembrolizumab 6 Specimen Handling 6 Methotrexate 6 Surgical Procedures, Operative 5 Topotecan 4 TIC10 compound 4 Isotretinoin 4 Carmustine 4 Carboplatin 4 abemaciclib 3 Trastuzumab 3 Thiotepa 3 Standard of Care 3 Nivolumab 3 Magnetic Resonance Imaging 3 Lomustine 3 Irinotecan 3 Erlotinib Hydrochloride 3 Drug Therapy 3 Dexamethasone 3 vandetanib 2 thymoglobulin 2 temsirolimus 2 pazopanib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × niraparib × CNS × Clear all

NCT05666349 2024-03-26

RiNG

University College, London

Phase 1 Withdrawn

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡